Clinical Trials

42 enrolled

HR Positive/HER-2 Negative Breast Cancer

NCT03500380 2024-02-20

A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases

Phase 2/3 Unknown

301 enrolled

Breast Diseases, Breast Neoplasms

NCT04400695 2024-01-24

A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2

366 enrolled

Breast Neoplasms

NCT05673694 2023-12-14

To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer.

70 enrolled

Breast Neoplasms

NCT04974567 2023-12-11

Tear Based Sample Collection Breast Cancer Detection

50 enrolled

Breast Neoplasms, Lacerations

NCT05268224 2023-12-11

A Tear-based, Lab-developed Test for Breast Cancer for Women With Dense Breast Tissue

1,500 enrolled

Breast Cancer Screening

NCT06149611 2023-11-29

Mass Balance Study of TQB3616

8 enrolled

Breast Neoplasms

NCT05792475 2023-11-27

Evaluation of TaiHao Breast Ultrasound Diagnosis Software RN-CES Descartes

3 enrolled

Breast Diseases, Breast Neoplasms

NCT05673629 2023-11-08

Utidelone in Combination With AC Versus Docetaxel in Combination With AC for Neoadjuvant Chemotherapy in Patients With HER2-negative Breast Cancer

552 enrolled

Breast Neoplasms

NCT05498597 2023-10-19

AMT-151 in Patients With Selected Advanced Solid Tumours

BreastGynecologicOther solid neoplasmThoracic

30 enrolled

Adenocarcinoma of Lung, Carcinoma, Ovarian Epithelial, Mesothelioma, Malignant, Carcinoma, Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT03129139 2023-10-18

Minnelide 101

66 enrolled

BreastGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Stomach Neoplasms

NCT03382340 2023-09-28

IMX-110 in Patients With Advanced Solid Tumors

BreastGastrointestinalGynecologic

70 enrolled

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms

NCT04165993 2023-09-21

Study of KN026 Monotherapy or Combination Therapy in Patients With Metastatic Breast Cancer

68 enrolled

Breast Neoplasms

NCT06047184 2023-09-21

Phase I Study of BEBT-209 in Women With Advanced Breast Cancer

106 enrolled

Advanced Breast Cancer

NCT05353361 2023-09-15

A Phase Ib/II Study of SHR-A1811 Injection in Breast Cancer

402 enrolled

Breast Neoplasms

NCT05755048 2023-09-01

FS-1502 Versus T-DM1 for HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer

314 enrolled

Breast Neoplasms

NCT04262804 2023-08-22

A Study to Evaluate the Efficacy and Safety of Margetuximab Plus Chemotherapy in the Treatment of Chinese Patients With HER2+ MBC

123 enrolled

Breast Cancer Metastatic

NCT03961698 2023-08-14

MARIO-3

91 enrolled

BreastGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms

NCT05985187 2023-08-14

Clinical Study to Evaluate the Efficacy and Safety of TQB2440 Injection/Perjeta® Combined With Trastuzumab and Docetaxel in the Treatment of Patients With Early or Locally Advanced Breast Cancer.

412 enrolled

HER2-positive Breast Cancer

NCT05845138 2023-08-01

A Study of SHR-A1811 Combined With Capecitabine in Treatment of Unresectable or Metastatic Breast Cancer With Low HER2 Expression.

116 enrolled

Breast Neoplasms

NCT04791384 2023-07-27

Phase Ib/II Trial of Abemaciclib and Elacestrant in Patients With Brain Metastasis Due to HR+/Her2- Breast Cancer

44 enrolled

Breast Neoplasms

NCT05433480 2023-07-27

A Study of BPI-16350 in Combination With Fulvestrant in Patients With HR+ and HER2- Locally Advanced, Recurrent or Metastatic Breast Cancer

274 enrolled

Breast Neoplasms

NCT05708950 2023-07-13

A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

314 enrolled

Breast Neoplasms, Carcinoma, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Sarcoma, Stomach Neoplasms, Thyroid Neoplasms, Uterine Neoplasms

NCT04928014 2023-07-03

Validation of a Tear-based Screening Assay for Breast Cancer

205 enrolled

Behavior, Breast Neoplasms, Patient Acceptance of Health Care

NCT05223218 2023-07-03

Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study

BreastDermatologicGastrointestinalGenitourinaryGynecologic

500 enrolled

Breast Neoplasms, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT05914168 2023-06-22

COBRIS

150 enrolled

Phase EARLY_PHASE1 Unknown

Breast Neoplasms

NCT05886075 2023-06-02

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

24 enrolled

BreastGastrointestinalGynecologicHead & NeckSarcomaThoracic

Breast Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms, Small Cell Lung Carcinoma

NCT03567720 2023-06-01

Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC

65 enrolled

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT04500262 2023-06-01

COMPULSE

479 enrolled

Breast Neoplasms

NCT05882019 2023-05-31

Evaluation of the Bexa™ Breast Examination (BBE)

700 enrolled

Phase EARLY_PHASE1 Unknown

Breast Neoplasms

NCT05860374 2023-05-16

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Advanced Solid Tumors

20 enrolled

BreastGastrointestinalSarcomaThoracic

Breast Neoplasms, Carcinoma, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Colorectal Neoplasms

NCT03613181 2023-04-24

ANGLeD

150 enrolled

BreastCNS

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

NCT04348643 2023-04-18

Safety and Efficacy of CEA-Targeted CAR-T Therapy for Relapsed/Refractory CEA+ Cancer

BreastGastrointestinalThoracic

40 enrolled

Breast Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05802342 2023-04-06

A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer

Phase 2/3 Unknown

150 enrolled

To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients

NCT05792410 2023-03-31

A Phase Ⅰb/Ⅱ Clinical Study of SHR-A1811 Combined With Other Therapies in Patients With HER2 Low Advanced or Metastatic Breast Cancer.

300 enrolled

Breast Neoplasms

NCT05790096 2023-03-29

Effectiveness and Safety Study of Filgrastine® in Patientes With Breast Cancer Treated With Myelotoxic Chemotherapy

60 enrolled

Breast Neoplasms

NCT05453591 2023-03-24

URODETECT-WP3

200 enrolled

Breast Neoplasms, Neoplasms

NCT05456373 2023-03-22

Intraoperative Use of ClearEdge Device in Breast Conserving Surgery

288 enrolled

Margins of Excision, Breast Neoplasms

NCT05633342 2023-03-20

CADENCE

BreastGastrointestinalGenitourinaryGynecologic

15,000 enrolled

Breast Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05775575 2023-03-20

A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer

65 enrolled

Advanced Breast Cancer

NCT05753865 2023-03-03

A Study to Evaluate the Efficacy and Safety in Patients With Advanced Breast Cancer Treated With SYHX2011 Compared to Paclitaxel for Injection (Albumin-bound)

454 enrolled

Advanced Breast Cancer

NCT04768868 2023-02-24

WEE1

BreastGastrointestinalGenitourinaryGynecologic

350 enrolled

Breast Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

NCT05738993 2023-02-22

A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of a Single Intravenous Infusion of BCD-178 or Perjeta® in Healthy Volunteers

100 enrolled

Breast Neoplasms

NCT02983071 2023-02-15

G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer

102 enrolled

Breast Neoplasms, Carcinoma, Ductal, Breast

NCT05453825 2023-01-31

A Study of Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors

BreastGastrointestinalGynecologic

180 enrolled

Ovarian Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT03775525 2022-12-23

GEN602

BreastDermatologicGastrointestinalHead & NeckLymphoidSarcoma

127 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Basal Cell, Colonic Neoplasms, Lymphoma, Pancreatic Neoplasms, Sarcoma, Stomach Neoplasms, Lymphoma, T-Cell, Cutaneous

NCT05263869 2022-12-02

A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients

99 enrolled

Breast Cancer With Liver Metastases

NCT03863223 2022-11-23

A Study of Pyrotinib in Combination With Trastuzumab and Docetaxel in Patients With HER2 Metastatic Breast Cancer

590 enrolled